Clearance of infection may be enhanced by IFN-γ use in adult patients with invasive fungal sepsis [87], and in a randomized double-blind clinical trial in trauma, a decreased incidence for ventilator-associated pneumonia was observed in patients with mHLA-DR < 30% receiving inhaled IFN-γ [74]. Here, IFNG is linked to ventilator-associated pneumonia.